Back

Apolipoprotein A-I infusions and cardiovascular outcomes in patients with acute myocardial infarction and hyperlipidemia

2 September 2024 (11:00 - 11:12)
Organised by: Logo
Congress Presentation Part of: Smaller trials, trial updates, and other studies on lipid therapy Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor C Michael Gibson

Harvard Medical School, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Cardiovascular Efficacy of Evolocumab in Patients with Obesity: Updates from FOURIER Trial
Doctor Y. Kang (Boston, US)
Slides Video
Presentation thumbnail
Alternative LDL cholesterol lowering strategy vs. high-intensity statin strategy: An individual patient data meta-analysis from the randomized RACING and LODESTAR trials
Professor M. Hong (Seoul, KR)
Slides Video
Presentation thumbnail
A randomised, placebo-controlled phase 3 study of plozasiran in patients with familial chylomicronemia syndrome
Professor G. Watts (Perth, AU)
Slides Video
Presentation thumbnail
ApoA-I Infusions and Burden of Ischemic Events after Acute Myocardial Infarction
Doctor G. Chi (Boston, US)
Slides Video

Access the full session

Session thumbnail
Smaller trials, trial updates, and other studies on lipid therapy
Video

The Event

Event poster

ESC Congress 2024

2 September 2024 11:00 CET
You may be interested in
thumbnail
Congress Session
Smaller trials, trial updates, and other studies on lipid therapy
thumbnail
Congress Session
Dyslipidaemia: novel diagnostics and therapy options
thumbnail
Congress Session
Late-Breaking Clinical Science: lipids and cardiovascular risk

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources